Rapid, label-free classification of glioblastoma differentiation status combining confocal Raman spectroscopy and machine learning

• Published in: Analyst (London) 2023-11, Vol.148 (23), p.619-6119
• Main Authors: Wurm, Lennard M, Fischer, Björn, Neuschmelting, Volker, Reinecke, David, Fischer, Igor, Croner, Roland S, Goldbrunner, Roland, Hacker, Michael C, Dyba, Jakub, Kahlert, Ulf D
• Format: Article
• Language: English
• Subjects: Algorithms; Heterogeneity; Labels; Lipids; Machine learning; Raman spectroscopy; Spectrum analysis; Stem cells; Tumors
• ISSN: 0003-2654; 1364-5528
• DOI: 10.1039/d3an01303k

Label-free identification of tumor cells using spectroscopic assays has emerged as a technological innovation with a proven ability for rapid implementation in clinical care. Machine learning facilitates the optimization of processing and interpretation of extensive data, such as various spectroscopy data obtained from surgical samples. The here-described preclinical work investigates the potential of machine learning algorithms combining confocal Raman spectroscopy to distinguish non-differentiated glioblastoma cells and their respective isogenic differentiated phenotype by means of confocal ultra-rapid measurements. For this purpose, we measured and correlated modalities of 1146 intracellular single-point measurements and sustainingly clustered cell components to predict tumor stem cell existence. By further narrowing a few selected peaks, we found indicative evidence that using our computational imaging technology is a powerful approach to detect tumor stem cells in vitro with an accuracy of 91.7% in distinct cell compartments, mainly because of greater lipid content and putative different protein structures. We also demonstrate that the presented technology can overcome intra- and intertumoral cellular heterogeneity of our disease models, verifying the elevated physiological relevance of our applied disease modeling technology despite intracellular noise limitations for future translational evaluation. Multifactor classification of tumor stem cells and their differentiated counterparts by label-free diagnostics.